This symposium proposal seeks to provide an annual review of the highest impact peer-reviewed publications and newsmaker events across the field of Addiction Psychiatry from 2024, as identified by Altmetric scores and expert opinion. The goal of this session is to provide concise, critical summaries of the most important peer-reviewed publications, organized using key topic areas to structure the presentation according to themes identified on review. We will provide more in-depth focus and panel discussion by diverse thought leaders in our field on a small, select group of articles that are high impact and likely to fundamentally change clinical practice.
Presentation Description High Impact Article Presentation (60 minutes): The chairs and presenters will prepare two slides per article with the basic design, key findings, implications, and discussion points. The panel discussants will then engage in a learning/teaching conversation with the presenters regarding each article. Each article will be allotted 5-8 minutes for presentation and discussion.
Audience Engagement and Discussion (30 minutes): The final 30 minutes of the Symposium will be open to the audience for further discussion and questions.
Carla Marienfeld, MD, Chairperson, Presenter
Carla Marienfeld, MD, DFAPA, FASAM is board-certified in psychiatry, addiction psychiatry, and addiction medicine, and she is a Clinical Professor at the University of California San Diego who supports recovery in an evidence based, harm-reduction approach through motivational interviewing and medication treatment. She was named a San Diego Top Doctor in 2021 as Medical Director for the UC San Diego Substance Treatment and Recovery (STAR) program. Her research involves populations with substance use disorders, including pregnant women and the development of their offspring, often using analysis of electronic medical record data. She has authored over three dozen peer reviewed articles, book chapters, practice guidelines, and invited commentaries, and she edited two books: Motivational Interviewing for Clinical Practice and Absolute Addiction Psychiatry Review: An essential board exam study guide. She has a record of grant funding for research and founding the UCSD Addiction Psychiatry Fellowship Program, where she serves as Program Director. She has been highly involved in the education of colleagues and trainees about addiction psychiatry, buprenorphine treatment, and motivational interviewing. Dr. Marienfeld completed a fellowship in addiction psychiatry and residency training in psychiatry at Yale. During her residency, she was chief resident of psychiatry and founded (and later led as junior faculty) the Yale Global Mental Health Program. She earned a medical degree with honors from Baylor College of Medicine in Houston. She is active in many professional organizations, including the American Society of Addiction Medicine, the American Association of Addiction Psychiatry, and the American Psychiatric Association.
Brian Hurley, MD, Presenter
Brian Hurley, MD, MBA, DFASAM, FAPA is an addiction physician and the Medical Director of the Bureau of Substance Abuse Prevention and Control in the Los Angeles County Department of Public Health and a volunteer assistant clinical professor of addiction medicine in the UCLA Department of Family Medicine. He is the President of the American Society of Addiction Medicine and gives presentations around the world regarding addiction medicine and motivational interviewing. He is a Primary Investigator for an award to the Los Angeles County Department of Public Health from the Substance Abuse Mental Health Services Administration's first Harm Reduction Grant Program and the Centers for Disease Control Overdose to Action:LOCAL award to Los Angeles County. Additionally, he is the grant lead for three Medications for Addiction Treatment Access Points projects funded by the Sierra Health Foundation supporting access to medications for addiction treatment across Los Angeles County. He is a member of the Motivational Interviewing Network of Trainers.
Joshua Lee, MD, Presenter
Joshua D. Lee MD, MSc is a Professor in the Department of Population Health and Dept. Medicine/General Internal Medicine and Clinical Innovation at the NYU Grossman School of Medicine. He is Program Director of the NYU Addiction Medicine Fellowship and Co-Director of DPH’s Section on Tobacco, Alcohol, and Drug Use. He is a clinician researcher focused on alcohol and opioid treatments in primary care and criminal justice populations and leads the NYUGSOM Hub of the NIDA Justice and Community Opioid Innovation Network. He is Science Advisor at Oar Health, an alcohol treatment provider.
Daryl Shorter, MD, Discussant
Dr. Daryl Shorter is a Diplomate of the American Board of Psychiatry and Neurology and is Board Certified in both General and Addiction Psychiatry. A graduate of Rice University (BA Sociology) and Baylor College of Medicine (MD), Dr. Shorter completed General Psychiatry residency at The Ohio State University Medical Center and Addiction Psychiatry fellowship at New York University/Langone Medical Center. Dr. Shorter is an Associate Professor in the Menninger Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine. He also serves as the Medical Director of Addictions and Recovery Services at the Menninger Clinic as well as the Program Director of the BCM Addiction Psychiatry fellowship. Dr. Shorter is the author of numerous peer-reviewed publications and book chapters focusing on medication treatment of substance use disorders and addictions training in graduate medical education. In addition to his work at Menninger, Dr. Shorter is the psychiatrist of record at The Montrose Center, Houston’s LGBTQ+ Behavioral Health and Community Center, where he supervises Addiction Psychiatry fellows who provide mental health and substance use disorder treatment services. He speaks widely on topics related to mental health, the LGBTQ+ community, and addictions treatment.
Larissa Mooney, MD, Discussant
Larissa Mooney, M.D. is a Professor of Clinical Psychiatry and Director of the Addiction Psychiatry Division in the Department of Psychiatry and Biobehavioral Sciences at UCLA. She is the Director of the UCLA-VA Addiction Psychiatry Fellowship Program and previously served as the Section Chief for Substance Use Disorders at the Greater Los Angeles VA. Dr. Mooney is the Immediate Past President of the American Academy of Addiction Psychiatry (AAAP), a Distinguished Fellow of the American Psychiatric Association (APA), and a Fellow of the American Society of Addiction Medicine (ASAM). She is one of two Principal Investigators for the Greater Southern California Node of the National Institute on Drug Abuse (NIDA) Clinical Trials Network.